Figure 1A. Efficacy Outcomes Stratified by Baseline …

Clinical Efficacy and Safety of Evolocumab in Patients with Baseline LDL-C. 70 mg/dL and non-HDL-C > 100 mg/dL, and in Patients Already. on. Maximal Statin: An Analysis from. FOURIER. 4. Robert P. Giugliano, Anthony C. Keech, Sabina A. Murphy, Kurt Huber, S. Lale Tokgozoglu, ................
................